LGALS3 and cancer: Indeed, MCP could inhibit cell adhesion in galectin-3-overexpressing tumor cells, reducing tumor cell aggregation and adhesion to the endothelial cells, thereby inhibiting the metastatic potential of cancer cells (323, 324).